AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PI

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new data across its broad oncology portfolio and pipeline at the European Society for...

Related Keywords

Madrid , Spain , Puerto Rico , United States , Granada , Andalucísp , Barcelona , Comunidad Autonoma De Cataluna , France , Spanish , French , America , Stevens Johnson , Jessica Akopyan , Justin Claeys , Amgen , Beigene Ltd , Youtube , World Best Companies , World Health Organization , Chemocentryx Inc , Teneobio Inc , Instagram , Drug Administration On , Kyowa Kirin Co Ltd , Linkedin , European Society For Medical Oncology , Twitter , Xencor Inc , Drug Administration , Exchange Commission , Results From Phase , Highlight Potential , Patients With Previously Treated , Data Support , Stage Results , Illustrate Expanding Potential , T Cell Engagers , European Society , Medical Oncology , Presidential Symposium Oral Presentation , Proffered Paper Oral Session , Presentation Times , Madrid Auditorium , Sevilla Auditorium , Results From , Granada Auditorium , Gastroesophageal Junction Cancer , Onsite Poster , Non Small Cell Lung Cancer , Barcelona Auditorium , Supplemental New Drug Application , Prescription Drug User Fee Act , Advanced Colorectal Cancer , Safety Information , Lung Disease , Common Adverse Reactions , Dow Jones Industrial Average , United States Today , Horizon Therapeutics ,